Neurobehavioral Manifestations

40 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Neurobehavioral Manifestations
Treatment and conditionWhere it standsTrials
ACP-204 for hallucinationsPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Acupuncture for agnosiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aticaprant for anhedoniaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Baclofen for psychomotor agitationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
BrainGate Neural Interface System for aphasiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BrainGate Neural Interface System for aphasia, brocaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BrainGate Neural Interface System for dysarthriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Buprenorphine hydrochloride for agnosiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Chronic speech BCI for speech disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Communication Bridge™ for aphasia, primary progressivePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Depression Cognitive Training + tDCS (active stimulation) for neurobehavioral manifestationsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Depression Cognitive Training + tDCS (sham stimulation) for neurobehavioral manifestationsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Divalproex sodium for maniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Donanemab for down syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Escitalopram oxalate for aphasiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Escitalopram oxalate for lethargyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
FLUOROETHOXYBENZOVESAMICOL F-18 for down syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fluoxetine for down syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
IM ketamine in dose finding and then continuation for phantom limbPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) for lethargyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
intermittent theta burst stimulation (iTBS) + METHYLPHENIDATE HYDROCHLORIDE for lethargyTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketoprofen for agnosiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Laboratory Biomarker Analysis + CYTARABINE + ASPARAGINASE ERWINIA CHRYSANTHEMI + ASPARAGINASE + Mitoxantrone Hydrochloride for down syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Laboratory Biomarker Analysis + CYTARABINE + ETOPOSIDE + THIOGUANINE + Daunorubicin Hydrochloride for down syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Leucovorin for language disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Levoleucovorin calcium for language disordersPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Lithium for maniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active) for lethargyPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
MRI + Psilocybin + Risperidone for anhedoniaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
N1 Implant + R1 Robot for dysarthriaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Non-Specific Cognitive Training + tDCS (sham stimulation) for neurobehavioral manifestationsTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for agnosiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Psilocybin for anhedoniaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT®) with the Magnus Neuromodulation System for memory disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
stimulation device for persistent vegetative stateTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Suzetrigine for agnosiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
the Terumo Hydropearl® microspheres device for agnosiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vagus nerve stimulation; for persistent vegetative stateTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Valproic acid for maniaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vasopressin for agnosiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1